article thumbnail

Doximity - the 'Linkedin for Doctors' is the best performing healthcare stock in 2025

Lloyd Price

Exec Summary As of February 23, 2025, Doximity (NYSE: DOCS), often dubbed the "LinkedIn for Doctors," has shown remarkable strength in the healthcare stock arena, positioning it as a standout performer this year. For the full fiscal year ending March 31, 2025, the company projects revenue between $564.6 million and $565.6

article thumbnail

Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group

Digital Health Global

With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries. Gerresheimer expects the acquisition to be accretive to the Group’s Adj. EBITDA margin and Adj.

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HealthTech M&A Multiples March 2025: Current Trends and Variables driving valuations

Lloyd Price

Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. The increase of distressed company M&A's is a large factor in the 2025 market. Average revenue multiples The average revenue multiple for HealthTech companies in March 2025 is 4.8x. This is down from 6.5x

article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. The wound care market is poised for significant growth in 2025 and beyond. These grafts are made from a patient's own cells, which reduces the risk of rejection.

article thumbnail

Sanguina Announces Ruby: The Evolution of AnemoCheck Mobile’s Blood Health Platform

Digital Health Global

Existing AnemoCheck Mobile users will automatically begin transitioning to Ruby when the app updates on April 1, 2025. Sanguina is a digital health and biotech company focused on advancing accessible digital and at-home health platforms. This makes it easier than ever to establish a baseline, spot trends, and stay on top of wellness.

BioTech 88
article thumbnail

Healthcare Startups Shine at Collision 2024

Healthcare IT Today

Innovative startups in the health IT, medical device, and biotech fields were among the shining stars at the annual Collision conference. In 2025 the conference heads to its new home in Vancouver, BC under its new banner – WebSummit Vancouver. The 2024 conference was held in Toronto, ON for the final time.

BioTech 127
article thumbnail

Affineon Secures $5M to Power Physician Productivity

Healthcare IT Today

With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech. Originally announced February 3rd, 2025 Affineon integrates seamlessly with EHR systems, saving providers time and enhancing the healthcare experience.

BioTech 52